Literature DB >> 11920319

Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity.

David E Greenberg1, Zhi-Dong Jiang, Robert Steffen, Mangala P Verenker, Herbert L DuPont.   

Abstract

The intestinal inflammatory response of traveler's diarrhea acquired in Goa, India, and Guadalajara, Mexico, was studied. Fecal lactoferrin was found in stool samples in which enteroaggregative Escherichia coli (EAEC), enterotoxigenic E. coli, or Salmonella or Shigella species were isolated, with Shigella-positive cases showing the highest level. Samples from cases of Shigella-associated diarrhea had the highest concentrations of fecal cytokines. Travelers to India who had EAEC-associated diarrhea showed elevated levels of interleukin (IL)-8 (median, 341.15 pg/mL) and IL-1beta (median, 749.90 pg/mL). Although 15 travelers to Mexico who had EAEC-associated diarrhea had a median concentration of 0 pg/mL for both IL-8 and IL-1beta, 2 had high levels of IL-8 (1853 and 11,786 pg/mL), and 5 showed elevated levels of IL-1beta (1-1240 pg/mL). Samples from patients in India who had pathogen-negative diarrhea or from patients in Mexico who had asymptomatic EAEC infection were negative for cytokines. Bacterial pathogens causing traveler's diarrhea commonly produce intestinal inflammation, although a subset of patients with EAEC-associated diarrhea fail to develop an inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920319     DOI: 10.1086/339617

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

1.  Enteroaggregative Escherichia coli: An Emerging Pathogen.

Authors:  David B. Huang; Hoonmo Koo; Herbert L. DuPont
Journal:  Curr Infect Dis Rep       Date:  2004-04       Impact factor: 3.725

Review 2.  Prevention and self-treatment of traveler's diarrhea.

Authors:  David J Diemert
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

Review 3.  Enteric infections, diarrhea, and their impact on function and development.

Authors:  William A Petri; Mark Miller; Henry J Binder; Myron M Levine; Rebecca Dillingham; Richard L Guerrant
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

4.  Human norovirus infection and the acute serum cytokine response.

Authors:  K L Newman; C L Moe; A E Kirby; W D Flanders; C A Parkos; J S Leon
Journal:  Clin Exp Immunol       Date:  2015-09-22       Impact factor: 4.330

5.  Association between TNF-alpha and Entamoeba histolytica diarrhea.

Authors:  Kristine M Peterson; Jianfen Shu; Priya Duggal; Rashidul Haque; Dinesh Mondal; William A Petri
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

Review 6.  Epidemiology and clinical manifestations of enteroaggregative Escherichia coli.

Authors:  Betina Hebbelstrup Jensen; Katharina E P Olsen; Carsten Struve; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

7.  Characterization and studies of the cellular interaction of native colonization factor CS6 purified from a clinical isolate of enterotoxigenic Escherichia coli.

Authors:  Abhisek Ghosal; Rudra Bhowmick; Rajat Banerjee; Sandipan Ganguly; S Yamasaki; T Ramamurthy; T Hamabata; Nabendu Sekhar Chatterjee
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

8.  Identification and molecular characterization of EatA, an autotransporter protein of enterotoxigenic Escherichia coli.

Authors:  Seema K Patel; Jimmie Dotson; Kenneth P Allen; James M Fleckenstein
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  Enteroaggregative Escherichia coli: An Emerging Enteric Food Borne Pathogen.

Authors:  P Kaur; A Chakraborti; A Asea
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-03-11

10.  A set of novel multiplex Taqman real-time PCRs for the detection of diarrhoeagenic Escherichia coli and its use in determining the prevalence of EPEC and EAEC in a university hospital.

Authors:  Christoph Hardegen; Sabine Messler; Birgit Henrich; Klaus Pfeffer; Jens Würthner; Colin R MacKenzie
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-01-22       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.